We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Updated: 12/31/1969
A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®
Updated: 12/31/1969
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®: Clinical Comparison in a Symptomatic Population
Status: Enrolling
Updated: 12/31/1969
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®
Updated: 12/31/1969
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®: Clinical Comparison in a Symptomatic Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Updated: 12/31/1969
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Updated: 12/31/1969
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Updated: 12/31/1969
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Updated: 12/31/1969
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimal Method for Mydriasis in Cataract Surgery
Updated: 12/31/1969
Optimal Method for Mydriasis in Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Optimal Method for Mydriasis in Cataract Surgery
Updated: 12/31/1969
Optimal Method for Mydriasis in Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
Updated: 12/31/1969
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
Status: Enrolling
Updated: 12/31/1969
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
Updated: 12/31/1969
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
Updated: 12/31/1969
A Pilot Study of Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)
Status: Enrolling
Updated: 12/31/1969
Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
Updated: 12/31/1969
A Pilot Study of Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Updated: 12/31/1969
Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cataract Refractive Suite Study
Updated: 12/31/1969
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Cataract Refractive Suite Study
Updated: 12/31/1969
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cataract Refractive Suite Study
Updated: 12/31/1969
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Cataract Refractive Suite Study
Updated: 12/31/1969
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cataract Refractive Suite Study
Updated: 12/31/1969
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Cataract Refractive Suite Study
Updated: 12/31/1969
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
Updated: 12/31/1969
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
Status: Enrolling
Updated: 12/31/1969
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
Updated: 12/31/1969
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
Updated: 12/31/1969
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated: 12/31/1969
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
Updated: 12/31/1969
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)
Updated: 12/31/1969
Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye
Updated: 12/31/1969
An 8-week, Phase II, Single-center, Randomized, Double-masked, Vehicle-controlled, Parallel-group Study With 4 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Patients With Dry Eye
Status: Enrolling
Updated: 12/31/1969
An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye
Updated: 12/31/1969
An 8-week, Phase II, Single-center, Randomized, Double-masked, Vehicle-controlled, Parallel-group Study With 4 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Patients With Dry Eye
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma
Updated: 12/31/1969
An 8 Week Phase Ib, Monocentric, Randomized, Double-masked, Parallel Groups, Study With a 24 Week Follow-up to Evaluate Safety and Potential Efficacy of a 180 μg/ml rhNGF Eye Drops Solution Vs Vehicle in Patients With Glaucoma
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma
Updated: 12/31/1969
An 8 Week Phase Ib, Monocentric, Randomized, Double-masked, Parallel Groups, Study With a 24 Week Follow-up to Evaluate Safety and Potential Efficacy of a 180 μg/ml rhNGF Eye Drops Solution Vs Vehicle in Patients With Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
Updated: 12/31/1969
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
Updated: 12/31/1969
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
Updated: 12/31/1969
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
Updated: 12/31/1969
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
Updated: 12/31/1969
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
Updated: 12/31/1969
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
Updated: 12/31/1969
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)
Updated: 12/31/1969
STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials